E-LIB Suche - Ergebnisse für: Alvarado, Y. J.

1

Surgical treatment of a patient with maxillary pseudoarthro..:

Alvarado, Y. ; Majia Florez, B.
International Journal of Oral and Maxillofacial Surgery. 52 (2023) - p. 6 , 2023

Link: https://doi.org/10.1016/..

2

P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY F..:

Venugopal, S. ; Jabbour, E. ; Pemmaraju, N....
HemaSphere. 6 (2022) - p. 480-481 , 2022

Link: https://doi.org/10.1097/..

3

P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WI..:

Bazinet, A. ; Jabbour, E. ; Kantarjian, H....
HemaSphere. 6 (2022) - p. 652-653 , 2022

Link: https://doi.org/10.1097/..

4

Effect of alginate on the removal of yellow 6 by a biopolym..:

Ortega-Aguirre, S. ; Díaz-Nava, M.C. ; Solache-Ríos, M....
Separation and Purification Technology. 292 (2022) - p. 120971 , 2022

Link: https://doi.org/10.1016/..

5

PB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE M..:

Ong, F. ; Kadia, T. M. ; Short, N. J....
HemaSphere. 6 (2022) - p. 1711-1712 , 2022

Link: https://doi.org/10.1097/..

6

P506: ACHIEVEMENT OF MEASURABLE RESIDUAL DISEASE CLEARANCE ..:

Bazinet, A. ; Kadia, T. ; Short, N....
HemaSphere. 6 (2022) - p. 405-406 , 2022

Link: https://doi.org/10.1097/..

7

P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TRE..:

Senapati, J. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 268-269 , 2022

Link: https://doi.org/10.1097/..

8

P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WI..:

Haddad, F. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 255-256 , 2022

Link: https://doi.org/10.1097/..

9

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGI..:

Ravandi, F. ; Jabbour, E. ; Jain, N....
HemaSphere. 6 (2022) - p. 265-266 , 2022

Link: https://doi.org/10.1097/..

10

P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ..:

Venugopal, S. ; kantarjian, H. ; Maiti, A....
HemaSphere. 6 (2022) - p. 679-680 , 2022

Link: https://doi.org/10.1097/..

11

P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PL..:

Abuasab, T. ; Alvarado, Y. ; Issa, G....
HemaSphere. 6 (2022) - p. 394-395 , 2022

Link: https://doi.org/10.1097/..

12

P575: IMPACT OF MOLECULAR RESPONSE AND CHEMOTHERAPY REGIMEN..:

Senapati, J. ; Haddad, F. ; Ravandi, F....
HemaSphere. 6 (2022) - p. 474-475 , 2022

Link: https://doi.org/10.1097/..

13

P769: MUTATION PROFILES AND RISK STRATIFICATION IN HYPOCELL..:

Kim, K. ; Chien, K. ; Faustine, O....
HemaSphere. 6 (2022) - p. 664-665 , 2022

Link: https://doi.org/10.1097/..

14

P770: A COMPARATIVE STUDY OF LEUKEMIC TRANSFORMATION IN THE..:

Kim, K. ; Ong, F. ; Li, Z....
HemaSphere. 6 (2022) - p. 665-666 , 2022

Link: https://doi.org/10.1097/..

15

P760: PATTERNS OF HYPOMETHYLATING AGENT FAILURE IN PATIENTS..:

Chien, K. ; Kim, K. ; Li, Z....
HemaSphere. 6 (2022) - p. 655-656 , 2022

Link: https://doi.org/10.1097/..